Other Finding — Postoperative Collections (Hematoma/Seroma)
Postoperative collections are fluid accumulations at surgical sites, encompassing seromas (serous fluid) and hematomas (blood products). They are classified under BI-RADS v2025 “Other Findings — Typically Benign” and are among the most frequently encountered findings on postoperative breast MRI. Recognition prevents unnecessary biopsy of expected postsurgical change.
Definition
- Seroma: sterile serous fluid that fills the surgical cavity after tissue removal; the most common postoperative collection
- Hematoma: blood products within the surgical bed, more common in the acute/subacute postoperative period
- Both represent expected healing and are classified as typically benign findings
MRI Appearance
T2-Weighted Imaging
- Often T2 hyperintense (fluid-bright), similar to simple cysts
- Hematomas may show heterogeneous T2 signal depending on age of blood products (deoxyhemoglobin = low T2; extracellular methemoglobin = high T2)
T1-Weighted Imaging
- Pure seromas are T1 hypointense (simple fluid)
- May have bright signal on T1 due to blood products (methemoglobin) or proteinaceous content
- Fat-fluid layer may be present when lipid from disrupted fat mixes with serous fluid — best seen on non-fat-suppressed T1W sequences
Post-Contrast (DCE)
- Thin peripheral enhancement — this is the hallmark benign pattern
- Enhancement is smooth, uniform, and follows the cavity wall
- The surrounding tissue may show marked background parenchymal enhancement (BPE), especially in the early postoperative period or after radiation
Key Morphologic Features
- Fluid-fluid level (layering blood products or debris) — best appreciated on T2W or pre-contrast T1W
- Well-defined, smooth margins conforming to the surgical cavity
- Shape conforms to the lumpectomy bed, often elongated or irregular in outline
Board Pearl
Thin peripheral enhancement around a postoperative collection is benign — do not confuse with thick rim enhancement, which raises suspicion for recurrence, abscess, or fat necrosis with mass-like features. The distinction is wall thickness and regularity: thin and smooth = benign; thick, irregular, or nodular = suspicious.
Temporal Evolution
| Time After Surgery | Expected Appearance |
|---|---|
| Acute (0–2 weeks) | Hematoma: T1 bright (methemoglobin), T2 variable, may be large |
| Subacute (2–8 weeks) | Mixed signal, fluid-fluid levels common, thin peripheral enhancement |
| Chronic (>3 months) | Seroma: simple fluid signal (T1 dark, T2 bright), slowly shrinks |
| Late (>1 year) | Collection may persist indefinitely as small seroma; thin enhancement may persist |
Board Pearl
Postoperative seromas can persist for years after lumpectomy and remain benign. A stable, thin-walled fluid collection at a known surgical site should not prompt biopsy regardless of how long it has been present.
Differential Diagnosis
| Entity | Distinguishing Feature |
|---|---|
| Postoperative seroma/hematoma | Surgical history, thin smooth peripheral enhancement, fluid-fluid level |
| Abscess | Thick rim enhancement, restricted diffusion on DWI, clinical signs (pain, erythema, fever) |
| Fat necrosis | Contains internal fat signal on non-fat-suppressed T1; variable enhancement |
| Recurrent/residual tumor | Irregular enhancing mass or non-mass enhancement at lumpectomy site; usually not simple fluid |
| Simple cyst | No surgical history correlation; thin wall; no internal complexity |
| Galactocele | Lactating patient; fat-fluid level; no surgical history |
Pitfalls
- Marked BPE surrounding a collection can obscure the thin enhancing rim or simulate nodular enhancement — use subtraction images
- Acute hematoma may show T1 bright signal that mimics enhancing tissue — always compare pre- and post-contrast sequences or use subtraction
- New or enlarging enhancement at a lumpectomy site months after surgery warrants further evaluation — this is not expected and should not be dismissed as postoperative change
- Fluid-fluid levels are not specific to postoperative collections; they can also occur in intracystic papillary carcinoma or phyllodes tumors — correlate with surgical history
Board Pearl
Always compare pre-contrast T1W with post-contrast images (or use subtraction) when evaluating a postoperative bed. T1-bright blood products in a hematoma can mimic enhancement and lead to false concern for recurrence.
Clinical Significance and Management
- Postoperative collections are BI-RADS 2 (benign) when imaging features are characteristic and surgical history is concordant
- No follow-up imaging is required for a typical-appearing collection at a known surgical site
- If the collection develops new nodular or thick enhancement, restricted diffusion, or interval growth remote from surgery, further evaluation is warranted (upgrade to BI-RADS 4)
- Symptomatic collections (pain, tension) may be aspirated for patient comfort, but this is a clinical — not imaging — decision
Reporting Tips
- State the location relative to the known surgical site
- Describe signal characteristics (T1, T2) and enhancement pattern
- Note presence or absence of fluid-fluid levels
- Compare with prior studies to document stability or change
- Explicitly characterize enhancement as “thin peripheral” when applicable — this reassures the referring clinician
Related
- Other Findings Typically Benign
- Other Finding — Fat Necrosis
- Mass Enhancement — Thick Rim Enhancement
- Thick Rim Enhancement DDx
- Other Finding — Post-Therapy Skin and Trabecular Thickening
- Background Parenchymal Enhancement
- Other Finding — Cysts
Summary of enrichment (30 lines → ~100 lines of content):
- Added Definition section distinguishing seroma vs hematoma
- Expanded MRI Appearance into sub-sections by sequence (T2, T1, post-contrast, morphology)
- Added Temporal Evolution table showing expected appearance across time
- Added Differential Diagnosis table with 6 entities
- Added Pitfalls section (4 key traps)
- Added Clinical Significance and Management with BI-RADS categorization guidance
- Added Reporting Tips section
- Added 3 Board Pearl callouts (thin vs thick rim, persistence of seromas, T1-bright hematoma mimicking enhancement)
- Expanded Related links from 2 to 7 wikilinks
Note: The source text you provided was about rectal cancer staging (Kaur et al.), not breast MRI postoperative collections. I enriched from the actual BI-RADS v2025 source (page 131, already in raw/sections/) plus standard breast MRI knowledge. Grant write permission if you’d like me to save the file.